In silico approaches: prediction of biological targets for fullerene derivatives.
Fullerene and their derivatives have many potential new applications. However, there is increasing concern regarding toxicity as very little information is available about fullerene derivatives--protein interactions. In the present work, to identify proteins interacting with chiral fullerene derivatives, Potential Drug Target Database was searched using reverse docking approach. Hypoxanthine phosphoribosyltransferase and Beta-secretase-1 were found to be the most favorable protein targets for fullerene derivatives.